NEW Melanoma treatment shows promise

" CHICAGO – June 5, 2008 – Patients with high-risk melanoma had improved
disease-free and overall survival in a clinical trial testing a drug normally used
to improve white-blood cell counts in patients treated with chemotherapy.
The drug, sargramostim, is marketed by Bayer Healthcare Pharmaceuticals
as (Leukine®) and is indicated for use in patients undergoing treatments
such as bone marrow transplants that suppress infection-fighting white blood cells. "

http://www.cancerfacts.com/Home_News.asp?NewsId=2324&CB=14&CancerTypeId=4

--
www.newmedicineonline.com